Chronic infections with human immunodeficiency virus (HIV), hepatitis B virus (HBV) or hepatitis C virus (HCV) add to age-dependent bone loss and may contribute to lower bone strength in the elderly. In this review, we report recent highlights on the epidemiology of bone fragility in chronic viral infections with HIV, HCV and HBV, its physiopathology and discuss the interference of antiviral therapies with bone metabolism. Chronic infections influence bone through the interactions between risk factors for bone fragility and falls (which are highly prevalent in infected patients), virus activity and antiviral drugs. HIV-infected patients are at increased risk of fracture and the risk is higher in cases of co-infection with HIV and untreated ...
International audienceWe assessed bone mineral density (BMD) in a cohort of human immunodeficiency v...
Objective: The purpose of our study was to evaluate the alterations of bone metabolism and the preva...
International audienceWe assessed bone mineral density (BMD) in a cohort of human immunodeficiency v...
<div><p>Objective</p><p>There is a variable body of evidence on adverse bone outcomes in HIV patient...
Life expectancy of people living with HIV (PLWH) is now close to that of the HIV-uninfected populati...
Highly active anti-retroviral therapy has transformed HIV into a chronic disease with a long-term as...
OBJECTIVE:: Few studies have examined the impact of viral hepatitis on bone mineral density (BMD), a...
With the advent of high active antiretroviral therapy there was a significant improvement on HIV sub...
Abstract HIV/hepatitis C virus (HCV) patients have a 3-fold increased fracture incidence compared to...
Recently, a high incidence of osteopenia and osteoporosis has been observed in individuals infected ...
Life expectancy of people living with HIV (PLWH) is reaching similar length as in the general popula...
Bone disorders such as osteopenia and osteoporosis have been recently reported in patients infected ...
Life expectancy of people living with HIV (PLWH) is reaching similar length as in the general popula...
Objective: The purpose of our study was to evaluate the alterations of bone metabolism and the preva...
International audienceWe assessed bone mineral density (BMD) in a cohort of human immunodeficiency v...
Objective: The purpose of our study was to evaluate the alterations of bone metabolism and the preva...
International audienceWe assessed bone mineral density (BMD) in a cohort of human immunodeficiency v...
<div><p>Objective</p><p>There is a variable body of evidence on adverse bone outcomes in HIV patient...
Life expectancy of people living with HIV (PLWH) is now close to that of the HIV-uninfected populati...
Highly active anti-retroviral therapy has transformed HIV into a chronic disease with a long-term as...
OBJECTIVE:: Few studies have examined the impact of viral hepatitis on bone mineral density (BMD), a...
With the advent of high active antiretroviral therapy there was a significant improvement on HIV sub...
Abstract HIV/hepatitis C virus (HCV) patients have a 3-fold increased fracture incidence compared to...
Recently, a high incidence of osteopenia and osteoporosis has been observed in individuals infected ...
Life expectancy of people living with HIV (PLWH) is reaching similar length as in the general popula...
Bone disorders such as osteopenia and osteoporosis have been recently reported in patients infected ...
Life expectancy of people living with HIV (PLWH) is reaching similar length as in the general popula...
Objective: The purpose of our study was to evaluate the alterations of bone metabolism and the preva...
International audienceWe assessed bone mineral density (BMD) in a cohort of human immunodeficiency v...
Objective: The purpose of our study was to evaluate the alterations of bone metabolism and the preva...
International audienceWe assessed bone mineral density (BMD) in a cohort of human immunodeficiency v...